BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma QC

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China

Carteyva® is an anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product independently developed by JW Therapeutics. T...

April 04, 2022 | News

Nippon Express Acquire GDP Certification in Middle East

The United Arab Emirates (UAE) has been making focused efforts to attract the healthcare industry, and numerous pharmaceutical manufacturers and ...

March 30, 2022 | News

eTheRNA Manufacturing Announces New LNP Formulation Development and Production Service

This new LNP service uses eTheRNA’s proprietary lipid libraries and proprietary formulations to facilitate targeted delivery and tailored biodistribu...

March 29, 2022 | News

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines

Daewoong Pharmaceutical (CEO Sengho Jeon & Changjae Lee) recently announced that it has submitted the New Drug Application (NDA) for a n...

March 29, 2022 | News

Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG

Furthermore, it also empowers the domestic precision immunotherapy for tumors and promotes the high-quality development of China's biopharmaceuti...

March 28, 2022 | News

Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin

DTX-021 is a botulinum toxin type A drug intended for the treatment of moderate to severe glabellar lines. DTX-021 is a highly purified and clinically test...

March 25, 2022 | News

Lynk Pharmaceuticals and Simcere announced Strategic Commercialization Partnership

Under the terms of the agreement, Lynk Pharmaceuticals is responsible for the development of the product. Simcere will obtain the exclusive rights to marke...

March 18, 2022 | News

Everest Medicines to further enhance its international commercial footprint

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical u...

March 14, 2022 | News

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by a...

March 08, 2022 | News

Accure Therapeutics licences neuroprotective drug candidate to ophthalmology company Oculis

First-in-class peptidomimetic with distinct MoA activating trophic signaling pathways to protect and prevent damage to the optic nerve and retina Potent...

March 03, 2022 | News

RosVivo signed MTA for diabetes treatment with Eli Lilly and Company

RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...

February 23, 2022 | News

Quotient Sciences completes integration of drug substance into translational pharmaceutics® platform

Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and bi...

February 18, 2022 | News

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

February 11, 2022 | News

Singapore (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative ph...

February 07, 2022 | News

Stay Connected